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Excessive Sleepiness?

Maybe an Illness:
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What is narcolepsy?
Narcolepsy. It affects 1 in
2,000 Americans, and over 3 million
people worldwide. It is not exactly
considered a “rare” disease, but it
often misdiagnosed or attributed
to something else. It seems like an
unimaginable illness: one minute
you’re awake and functioning
normally, the next minute you’re
suddenly asleep. A person with
narcolepsy will suffer from “sleep
attacks”: unexpected episodes
of excessive daytime sleepiness1.
Often times they are triggered by
intense emotions, like laughter or
anger2. This is called cataplexy,
which means that the person loses
muscle tone and collapses while
being conscious2. Currently, there
is no cure for narcolepsy. Although
there are an assortment of drugs
and medications used to treat the
symptoms, narcoleptic patients
have to carefully monitor their
illness for the rest of their lives.
Living with narcolepsy is no easy
task, it impedes everyday activities
and social life, forcing many to
quit their jobs and relinquish their
independence.
Narcolepsy can develop at
any point of a person’s life. Although
we do not know the definite cause
of why this happens, scientists know
that the loss of orexin-producing
neurons result in narcoleptic
symptoms3. Orexin, also known as
hypocretin, is a hormone produced
in the hypothalamus of our brain.
It is essential because it promotes
wakefulness and helps regulate
our wake and sleep cycles. When
orexin-producing neurons die,
orexin production and levels drop
below normal. Without sufficient
levels of orexin, the body cannot
keep itself awake and is thus
susceptible to excessive daytime
sleepiness and sleep attacks3.

Figure 1: Schematic representation of inputs and outputs of orexin neurons.
On CC

What causes
narcolepsy?
There are a few hypotheses
to what causes this disease.
The most popular one is the
autoimmune hypothesis1,2,5. Many
years of research and scientists
have backed this up, believing
narcolepsy to be an autoimmune
disease. But first we will discuss
what an autoimmune disease
is. An autoimmune di-sease is
characterized by an individual’s
own immune system attacking
their body. This occurs when the
immune system can no longer
tell the difference between the
body’s own healthy cells and
foreign pathogens. What triggers
an autoimmune response is not
known for certain, but some people
may have a genetic predisposition
for developing these diseases1.
Sometimes autoimmune diseases
may be triggered by infection, like
strep throat. The body’s immune
system makes T cells and B cells,
both being the main lines of
defense against foreign invaders.

T cells recognize cells infected with
the virus and kill them. T cells also
help produce B cells, which secrete
antibodies that bind to antigens.
The antibodies increase the immune response and the body’s
fight against antigens, which is an
infection. Sometimes the immune
response can go wrong, and this is
what starts an autoimmune disease.
The antibodies produced to fight an
infection accidentally start binding
to healthy cells and mislabeling
them as the antigen. The immune
system does not realize they are
making a mistake and continue
to attack healthy cells, which can
lead to the immune system itself
weakened.
The autoimmune hypothesis of narcolepsy postulates
that the disease is caused by the
immune system attacking the
orexin-producing neurons in the
hypothalamus of the brain1. Some
studies have pointed out the
increased incidence of narcolepsy
after an upper respiratory infection6.
Although
correlation
cannot
determine causation, it is thought
that the antibodies produced to

96

SCIENTIFIC KENYON
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fight the infection somehow end
up attacking the neurons as well.
The mechanism by which it occurs
is currently unknown1.

but too many confounding results
keep this uncertain. Although this
gene is a key player in narcolepsy
development, environmental factors such as prior infections also
greatly influence disease onset6.

Can narcolepsy be in
your genes?
How is Narcolepsy
Narcolepsy has also been Diagnosed?
strongly linked to the human
leukocyte antigen gene HLA
DQB1*06:027,8. Genetic studies
have concluded that over 90%
of narcoleptic patients have this
gene8. But why is this significant or
even important? This specific HLA
gene is part of a family of genes,
also known as the human leukocyte
antigen (HLA) complex. The HLA
complex helps your immune system
in distinguishing between the
proteins your own body produces
and the proteins produced by
pathogens. If this was somehow
out of order, our immune system
could attack itself or fail to protect
the body from infections. The
HLA DQB1*06:02 gene is thought
to provide the instructions for
making the proteins present on the
surface of immune cells8. This HLA
protein produced partners up with
another protein to form an antigenbinding complex. This complex
binds and displays the foreign
antigens to the rest of the cells in
the immune system to trigger a
response. Many studies have been
done to explore the mechanisms
of the HLA DQB1*06:02 gene’s
effect on orexin-producing neurons
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Narcolepsy must be diagnosed by a healthcare professional,
like a primary care doctor or
neurologist. There are two tests
that are essential in diagnosis. The
first is the polysomnogram and
the second is the multiple sleep
latency test (MSLT). Having the
patient fill out a questionnaire, like
the Epworth Sleepiness Scale, is
also commonly utilized to examine
if the excessive daytime sleepiness
criteria is met.
The MLST measures sleep
latency. This is defined as the time
it takes from the start of a daytime

nap to the first sign of sleep9. If a
person has narcolepsy, it should
not take them long to fall asleep,
usually less than 5 minutes. In
the graph to the left, “SL” in red
indicates the sleep latency. This
graph would be an example of the
MLST recordings of a narcoleptic
patient. In a polysomnogram, a
variety of other data is collected
about the individual’s sleep. A
polysomnography will record brain
waves, heart rate, breathing, eye
and leg movements, etc. These
recordings will allow the doctors
to visual how the individual moves
through different stages of sleep
and catch any abnormalities in
sleep pattern. In a normal sleep
cycle, an individual will reach rapid
eye movement (REM) sleep about
60 to 90 minutes after they go to
bed. For a narcoleptic individual,
REM sleep is achieved much faster,
in about 15 minutes.
Another test helpful in
with
diagnosing
narcolepsy
cataplexy is performing a spinal
tap10. A needle will be inserted
into the patient’s spine area to
obtain a sample of cerebrospinal
fluid. Doctors can look at the
cerebrospinal fluid to measure
orexin levels in the body10. If they
are lower than normal, it indicates
the loss of orexin-producing
neurons and thus narcolepsy..
Narcolepsy can also present
symptoms other than excessive
sleepiness or cataplexy.
Many

Stages of Sleep on Wikimedia Commons
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Figure 3. How the H1N1 virus and vaccine cross the blood brain barrier and attack orexin-producing neurons. Image
courtesy of Partinen, Markku et al. 2014.

report poor quality of sleep, trouble
falling asleep at night, inability to
move when falling asleep or waking
up, hallucinations, and extreme
increase in appetite.

Does the H1N1
vaccine and
narcolepsy support
the autoimmune
hypothesis?
Back in April of 2009, fear
spread nationwide.
Reports of
an outbreak of a new influenza A
virus spread throughout the U.S.
This new virus, also called H1N1
influenza or “swine flu” spread

quickly across the U.S. and other
countries. At the time, the H1N1
pandemic caused a lot of panic.
It was unlike other viruses seen
before, made up of a combination
of viral genes not seen in animals
or humans previously. Seasonal
flu vaccines available for the
public did not provide protection
against the H1N1 influenza, and
an H1N1 specific vaccine was not
available until after the peak of the
pandemic. The CDC estimated
that about 12,500 people in the
U.S. died due to the virus.
Later in the year, reports
of an increased incidence of
childhood narcolepsy after H1N1
vaccination appeared in Finland
and Sweden11,12. By the beginning
of 2010, other countries also began
reporting the same thing. It seemed

that diagnoses of narcolepsy had
increased dramatically in the year
following the H1N1 pandemic, with
a possible link to a specific H1N1
vaccine: Pandemrix13.
There were two different
kinds of vaccines available for
injection: Pandemrix and Arepanrix.
Both were very similar to each other
but were not produced in the same
way. They differed in the method
in which the H1N1 antigen was
isolated and purified. Pandremix
ended up having a higher amount
of structurally altered viral protein
compared to Arepanrix13.
The
higher amount of the viral protein
in Pandemrix may have caused
too much of an immune response
and thus triggering an attack on
orexin-producing neurons. Initially,
scientists thought that both
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time passes more and more
healthy cells are being destroyed,
the immune system rages out
of control, and it turns into an
autoimmune disease.
Since we
only saw incidence of narcolepsy
with patients that received the
Pandemrix vaccine, researchers
have come to believe that either
of the two possibilities, or even
both, occurred. The introduction
of the vaccine may have triggered
an exceptionally large immune
response where lymphocytes were
wrongly programmed to attack the
orexin-producing neurons.

Reports of Narcolepsy in
Finland and Sweden after
Vaccination

In figure A, the patient lies in a bed with sensors attached to the body. In figure B,
the polysomnogram recording shows the blood oxygen level, breathing event,
and rapid eye movement (REM) sleep stage over time.
A Polysomnogram on Wikipedia Commons

vaccines were linked to narcolepsy.
However, thorough review of
vaccination records revealed that
Pandemrix was widely distributed
and administered across Europe.
On the other hand, Arepanrix was
used in Canada and South America.
This may be why Finland and
Sweden saw a dramatic increase in
childhood narcolepsy.
What is hypothesized to
have happened here is that the
vaccine triggered an immune
response that was too big7,14.
The amount of the viral antigen
introduced to the host body may
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have caused the immune system
to go into overdrive. One possible
idea is that the T cells and B cells
were overproduced14.
Another
possible idea is that mutant T
cells and B cells are produced
and released without the body
realizing14.
These mutant cells
can be dysfunctional in that they
are programmed to recognize the
proteins on healthy cells and attack
them instead of invaders. If the
immune system does not realize it
is producing dysfunctional immune
cells and continues to churn them
out, we have a big problem. As

Many of the people reported
to have developed narcolepsy
after Pandemrix vaccination were
children under 17 years of age.
Narcolepsy is a rare occurrence in
children, especially under 10 years
of age. One of the earliest cases
report a 7 year old Finnish boy,
complaining of excessive daytime
sleepiness by December of 2009.
At this point the pandemic was still
ongoing and he had received the
Pandemrix vaccine. He did not have
a history of an upper respiratory
infection, allowing doctors to rule
that out as a triggering factor. Only
a few months later, in February of
2010, the boy was diagnosed with
narcolepsy. By August, 14 more
diagnoses of narcolepsy were
confirmed. They were just like
that first boy: young, no history of
upper respiratory infection, and
receivers of the Pandemrix vaccine.
Finland decided to halt the usage
of Pandemrix and pulled it out of
the market. As Finland began
to investigate the link between
Pandemrix and the increase in
narcolepsy, several similar cases appeared from Sweden and France.
You can see in the year
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Year

2000-2009

2010

Number of Narcolepsy Diagnoses

335
(~48 per year)

101

Incidence Rate

0.79/100,000

0.79/100,000

Figure 7. Data courtesy of Partinen, Markku, et al. (2012).

after Pandemrix vaccine was
administered that both the number
of diagnoses and incidence rate
spiked. In just 2010 alone, 101
new diagnoses of narcolepsy were
made. This is more than twice the
average amount from the previous
years. Out of the 335 people
diagnosed within a 7 year span,
only 26 were under 17 years of
age. This averages out to almost 4
kids each year. On the other hand,
out of the 101 new diagnoses in
one year, 54 were younger than 17
years of age.

Conclusion
The abnormal immune
response triggered by Pandemrix
vaccine seems to play a crucial
part in the loss of orexinproducing neurons characteristic of
narcolepsy. This event highlights
the need for more research on how
and why autoimmune diseases
occur.
Genetic predisposition,
family history, physical trauma or
injury, ethnic background, medical
history, etc. are all factors that

differ with each individual and
can contribute differently to their
immune response. Knowing that
even a simple vaccination could
initiate an abnormal response,
further knowledge is necessary
for protecting ourselves when our
bodies turn on us.

Pandremix on Wikimedia Commons
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